Healthcare

GLG News^SM Analyses in Healthcare

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Clinical lab testing trends

February 7, 2012

Analysis by:Ken Powell, President,

Several emerging trends could impact commercial reference lab revenue.  They include developments in pre-certification programs, molecular diagnostic and Laboratory Developed Test (LDT) registries, reimbursement programs and codes and test formularies.

Ketamine to treat severe depression

February 2, 2012

Analysis by: GLG Expert Contributor

Ketamine got its start as a veterinarian tranquilizer and  later it appeared as a club drug called “Special K”.  About 10 years ago a group of physicians in Connecticut noticed that Ketamine helped to improve depressive symptoms when it was given to children as a general anesthetic.

What do the cloud, collaboration and virtualization have in common?

January 27, 2012

Analysis by:Ken Kalinoski, President and General Partner,

With so much talk and buzz about cloud (computing, storage, application sharing) and Virtualization (server & desktop), it can seem as if though these two IT consolidation trends are trumping the Collaboration movement.  Service Providers across the map have readied themselves for cloud computing by partnering with infrastructure and networking providers.  Carrier clouds are all the rage: If you’re not selling cloud your customers are likely looking at alternatives.  Virtualization services have dramatically increased since the days of pervasive computing, the reawakening VMware anything (server appliances and server blades) and screen scraping data movers and mungers (aka Citrix).

New competitor enters ovarian cancer test market

January 26, 2012

Analysis by:Ken Powell, President,

Laboratory Corporation of America Holdings (LabCorp ) announced the launch of its FDA-cleared risk stratification tool that aids in the diagnosis of ovarian masses prior to planned surgeries. This new test could be a competitor to Vermillion’s OVA1 which is marketed by partner Quest Diagnostics.

Trends in physician office practices

January 17, 2012

Analysis by:Ken Powell, President,

American Hospital Association statistics show that the number of physicians employed by hospitals has grown 32% since 2000.  In-office lab testing continues to be strong revenue source for doctors faced with decreasing reimbursement rates.  Mobile connectivity continues to thrive.